ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

AKRO Akero Therapeutics Inc

19,71
-0,37 (-1,84%)
02 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Akero Therapeutics Inc AKRO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,37 -1,84% 19,71 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
20,44 19,64 20,44 19,71 20,08
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/04/202409:00GLOBEAkero Therapeutics Appoints Scott Gangloff as Chief..
08/03/202418:02GLOBEAkero Therapeutics Announces Closing of Public Offering of..
07/03/202418:01GLOBEAkero Therapeutics Announces Publication of Phase 2b..
05/03/202423:13GLOBEAkero Therapeutics Announces Pricing of Public Offering of..
05/03/202408:05IHMARKETNEWSAMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on..
04/03/202418:21GLOBEAkero Therapeutics Announces Proposed Public Offering of..
04/03/202408:00GLOBEAkero Therapeutics Reports Statistically Significant..
29/02/202410:00GLOBEAkero Therapeutics to Present Topline Week 96 Results from..
29/02/202409:00GLOBEAkero Therapeutics Reports Fourth Quarter and Full Year 2023..
03/01/202410:15GLOBEAkero Therapeutics to Present at the 42nd Annual J.P. Morgan..
18/12/202309:00GLOBEAkero Therapeutics Announces First Patients Dosed in..
13/11/202309:00GLOBEAkero Therapeutics Reports Third Quarter 2023 Financial..
10/11/202310:57GLOBEAkero Therapeutics to Present Late-Breaking Oral and Poster..
08/11/202309:00GLOBEAkero Therapeutics to Present at Upcoming Healthcare..
17/10/202317:05GLOBEAkero Therapeutics to Present at the H.C. Wainwright 7th..
10/10/202308:00GLOBEAkero Therapeutics Reports Encouraging 36-Week Analysis of..
09/10/202317:05GLOBEAkero Therapeutics to Present Results from Phase 2b SYMMETRY..
04/10/202309:00GLOBEAkero Therapeutics Announces Publication of the Harmony..
31/08/202308:00GLOBEAkero Therapeutics to Present at Upcoming Healthcare..
29/08/202308:22IHMARKETNEWSTuesday’s Wall Street Highlights: Alphabet, Verizon, Joann,..
11/08/202307:00GLOBEAkero Therapeutics Reports Second Quarter 2023 Financial..
23/06/202308:00GLOBEAkero Therapeutics Presents Analyses of Phase 2b HARMONY..
05/06/202308:00GLOBEAkero Therapeutics’ Phase 2b SYMMETRY Cohort D Study Met..
01/06/202317:05GLOBEAkero Therapeutics to Present Results from Phase 2b..
31/05/202309:00GLOBEAkero Therapeutics to Present at the Jefferies Healthcare..
16/05/202319:53GLOBEAkero Therapeutics Announces Pricing of $220.0 Million..
15/05/202308:00GLOBEAkero Therapeutics Reports First Quarter 2023 Financial..

Seu Histórico Recente

Delayed Upgrade Clock